Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
$4.27
$4.27
$0.78
$4.40
$891.09MN/A1.99 million shsN/A
Embecta Corp. stock logo
EMBC
Embecta
$14.38
+4.0%
$10.96
$9.20
$21.48
$808.85M1.08717,430 shs883,795 shs
InMode Ltd. stock logo
INMD
InMode
$14.81
+4.2%
$14.29
$13.14
$19.85
$898.20M1.931.13 million shs1.10 million shs
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$2.88
+1.4%
$2.36
$1.54
$3.05
$257.46M1.51877,296 shs545,317 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
0.00%0.00%0.00%0.00%0.00%
Embecta Corp. stock logo
EMBC
Embecta
-0.43%-0.29%+29.37%+29.01%+2.98%
InMode Ltd. stock logo
INMD
InMode
+0.14%-0.49%-1.39%-0.14%-11.24%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-0.35%-2.07%+27.35%+37.20%+51.06%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/AN/AN/AN/AN/AN/AN/A
Embecta Corp. stock logo
EMBC
Embecta
4.8469 of 5 stars
3.23.03.30.04.03.33.8
InMode Ltd. stock logo
INMD
InMode
2.0488 of 5 stars
2.12.00.00.02.61.71.9
Stereotaxis Inc. stock logo
STXS
Stereotaxis
0.1812 of 5 stars
0.01.00.00.00.61.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
0.00
N/AN/AN/A
Embecta Corp. stock logo
EMBC
Embecta
2.33
Hold$19.0032.13% Upside
InMode Ltd. stock logo
INMD
InMode
2.13
Hold$18.0421.82% Upside
Stereotaxis Inc. stock logo
STXS
Stereotaxis
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest STXS, INMD, CVRS, and EMBC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/30/2025
InMode Ltd. stock logo
INMD
InMode
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
7/30/2025
InMode Ltd. stock logo
INMD
InMode
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$24.00 ➝ $21.00
7/16/2025
Embecta Corp. stock logo
EMBC
Embecta
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$13.00 ➝ $12.00
7/11/2025
InMode Ltd. stock logo
INMD
InMode
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$15.00
5/23/2025
Embecta Corp. stock logo
EMBC
Embecta
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$25.00
5/23/2025
Embecta Corp. stock logo
EMBC
Embecta
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$15.00 ➝ $13.00
(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/AN/AN/AN/AN/A
Embecta Corp. stock logo
EMBC
Embecta
$1.12B0.75$3.47 per share4.15($11.45) per share-1.26
InMode Ltd. stock logo
INMD
InMode
$394.82M2.37$1.90 per share7.79$9.94 per share1.49
Stereotaxis Inc. stock logo
STXS
Stereotaxis
$26.92M9.70N/AN/A$0.02 per share144.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/A0.00N/AN/AN/AN/AN/A
Embecta Corp. stock logo
EMBC
Embecta
$78.30M$1.434.744.680.777.58%-23.40%14.46%N/A
InMode Ltd. stock logo
INMD
InMode
$181.27M$2.476.008.14N/A44.50%18.38%16.35%10/29/2025 (Estimated)
Stereotaxis Inc. stock logo
STXS
Stereotaxis
-$24.05M-$0.28N/AN/AN/A-73.43%-440.00%-50.62%11/10/2025 (Estimated)

Latest STXS, INMD, CVRS, and EMBC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/8/2025Q3 2025
Embecta Corp. stock logo
EMBC
Embecta
$0.7720$1.12+$0.3480$0.78$278.15 million$295.50 million
7/30/2025Q2 2025
InMode Ltd. stock logo
INMD
InMode
$0.50$0.47-$0.03$0.42$98.45 million$95.60 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/AN/AN/AN/A
Embecta Corp. stock logo
EMBC
Embecta
$0.604.17%N/A41.96%N/A
InMode Ltd. stock logo
INMD
InMode
N/AN/AN/AN/AN/A
Stereotaxis Inc. stock logo
STXS
Stereotaxis
N/AN/AN/AN/AN/A

Latest STXS, INMD, CVRS, and EMBC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/6/2025
Embecta Corp. stock logo
EMBC
Embecta
quarterly$0.155.79%8/29/20258/29/20259/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/AN/AN/A
Embecta Corp. stock logo
EMBC
Embecta
N/A
2.47
1.78
InMode Ltd. stock logo
INMD
InMode
N/A
9.60
8.58
Stereotaxis Inc. stock logo
STXS
Stereotaxis
N/A
1.06
0.59

Institutional Ownership

CompanyInstitutional Ownership
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/A
Embecta Corp. stock logo
EMBC
Embecta
93.83%
InMode Ltd. stock logo
INMD
InMode
68.04%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
45.35%

Insider Ownership

CompanyInsider Ownership
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
N/A
Embecta Corp. stock logo
EMBC
Embecta
0.42%
InMode Ltd. stock logo
INMD
InMode
6.92%
Stereotaxis Inc. stock logo
STXS
Stereotaxis
17.77%
CompanyEmployeesShares OutstandingFree FloatOptionable
Corindus Vascular Robotics Inc stock logo
CVRS
Corindus Vascular Robotics
90208.69 millionN/ANot Optionable
Embecta Corp. stock logo
EMBC
Embecta
2,10058.49 million58.24 millionOptionable
InMode Ltd. stock logo
INMD
InMode
48063.21 million58.84 millionOptionable
Stereotaxis Inc. stock logo
STXS
Stereotaxis
13090.65 million74.55 millionNot Optionable

Recent News About These Companies

Stereotaxis Reports 2025 Second Quarter Financial Results
Stereotaxis (STXS) to Release Earnings on Thursday
Stereotaxis (STXS) Gets a Buy from TD Cowen
Stereotaxis Wins FDA Nod for Catheter
Stereotaxis announces $12.5M offering
Stereotaxis Sinks on Common Stock Offering
Stereotaxis, Inc. (STXS) - Yahoo Finance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Corindus Vascular Robotics stock logo

Corindus Vascular Robotics NYSEAMERICAN:CVRS

$4.27 0.00 (0.00%)
As of 11/27/2019

Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.

Embecta stock logo

Embecta NASDAQ:EMBC

$14.38 +0.55 (+3.98%)
Closing price 04:00 PM Eastern
Extended Trading
$14.38 +0.00 (+0.03%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

InMode stock logo

InMode NASDAQ:INMD

$14.81 +0.60 (+4.22%)
Closing price 04:00 PM Eastern
Extended Trading
$14.69 -0.12 (-0.81%)
As of 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Stereotaxis stock logo

Stereotaxis NYSEAMERICAN:STXS

$2.88 +0.04 (+1.41%)
Closing price 04:10 PM Eastern
Extended Trading
$2.90 +0.02 (+0.87%)
As of 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.